What are you looking for?

Conferences

ISPOR Europe 2018

ISPOR is recognized globally as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in healthcare decisions. ISPOR Barcelona will feature three thought-provoking plenary sessions and more than 2500 presentations in the form of workshops, issue panels, forums, symposia, and podium and poster presentations on innovative research methods, health policy development using outcomes research, patient preferences, real-world data, and clinical-, economic-, and patient-reported outcomes.

Past

Schedule

13 November

13:00 to 15:00

S Djurdjevic

Modeling the population years of life saved by introducing a reduced risk product in the US and in Japan

S. Djurdjevic_ MODELING THE POPULATION YEARS OF LIFE SAVED BY INTRODUCING A REDUCED RISK PRODUCT IN THE US AND IN JAPAN
1208 KB

14 November

12:00 to 15:00

C Acquadro

Measurement Properties of translated versions of measures assessing the subjective effects of tobacco and nicotine containing products: A literature review

N.Nelly_Measurement properties of translated versions of measures assessing the_
629 KB

14 November

12:00 to 15:00

C Chrea

Development of a fit-for-purpose tobacco and nicotine product dependence instrument

C. Chrea_Development of a fit-for-purpose tobacco and nicotine product dependence instrument
1217 KB
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced-risk products ("RRPs") is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.